notification_important

MHRA alerts & recalls

Review medicine recalls, record your assessment and keep track of follow-up actions.

All alerts

Read the alert. Keep a record of your response.

Create a free PharmData login to receive notifications. An active Starter or Pro subscription enables your pharmacy team to record assessments and follow-up actions.

Create a free account Sign in

2023-08-31 12:00:50 · Revision 1

Class 4 Medicines Defect Information: Kyowa Kirin Limited, Tostran (Testosterone, 2% gel), EL (23)A/33

Kyowa Kirin Limited has notified MHRA that the priming instructions in the current PIL for Tostran 2% gel require updating.

Read full MHRA notice ↗

Source: Medicines and Healthcare products Regulatory Agency (MHRA). Read the full notice, including its required actions and deadlines, before recording your response.